Dr. Kerry Assil to Complete Final FDA-Supervised Implants of Presbia Flexivue Microlens™

Share Article

Renowned eye surgeon among first in study to improve near vision

Dr. Kerry Assil

"Having successfully inserted the Presbia Microlens in patients outside of the U.S., it's very exciting to see the conclusion of our U.S. FDA patient enrollment.” ~Dr. Kerry Assil

Today, renowned eye surgeon, Dr. Kerry Assil will perform surgery on the last two patients, who will be enrolled in the final phase of the Presbia Flexiuve Microlens™ as part of an FDA study. The study began last year, when he was the first to implant the lens. The Presbia Flexivue Microlens is a revolutionary optical lens implant designed to treat presbyopia - the age-related loss of near vision - and has been commercially available in Europe and other countries around the world where it has obtained regulatory approval.

Dr. Assil, who is at the forefront of research and technology in eye surgery, was one of the first surgeons in the world, to implant the Microlens (overseas), nearly 15 years ago. The Presbia Flexivue Microlens is a microscopic implant made of hydrophilic acrylic and shaped like a contact lens. It is implanted in the cornea of the eye using the same type of laser used in LASIK procedures. Once inserted, it enables the eye to see both near and far.

"Having successfully inserted the Presbia Microlens in patients outside of the U.S., it's very exciting to see the conclusion of our U.S. FDA patient enrollment,” said Dr. Assil. “The Microlens appears to be a promising Presbyopia correcting technology, as unlike other alternatives, it can profoundly improve the near vision, without significantly affecting distance clarity."

Impacting more than 100 million Americans, presbyopia is a common progressive loss of near vision occurring in individuals primarily between 45-60 years old, causing the need for reading glasses. This is the first of the surgeries, within the study, to be performed in the United States. In a study of the Microlens conducted in Greece and Italy, 97% of patients reported “excellent” or “good” perception of binocular near and distance vision 12 months after implantation of the Microlens.

“We are very pleased to be associated with Dr. Assil and excited for the achievement of this important first step for the United States market,” said Microlens inventor and Presbia’s Chief Technology Officer, Vladimir Feingold.

Dr. Kerry Assil is a world-renowned eye surgeon and innovator, who continues to make significant advances in his field as a leader in research and state-of-the-art technology. In addition to his Beverly Hills & Santa Monica, Calif. practices, Dr. Assil continues to train thousands of physicians in refractive and cataract surgery as well as being a regular media expert. As the physician of choice for the Los Angeles Kings and numerous A-list celebrities, such as Brad Pitt, Dr. Assil is sought after by patients who travel from around the world to be treated by the best. His expertise has been featured on "The Doctors," "The Swan," Good Morning America,” “The Today Show,” Wall Street Journal, US News & World Report, Los Angeles Times, USA Today, Time, People Magazine, and InTouch, among many others.

For additional information on Dr. Assil, please visit The Assil Eye Institute. Both Dr. Assil and patients are available for interviews as well as filming, upon request.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Candis Melamed
Spotlight Communications Group
+1 (310) 613-1626
Email >
@SpotlightComGrp
Follow >
Visit website